ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,839Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 2888

$1.93M Total Retail Price of All Prescriptions

Rank: 29 out of 2888

800 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 800 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

25% of this provider’s 800 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 28,774 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 1,170 1,064 1 2
LEVOTHYROXINE SODIUM 1,076 1,060 2 1
FUROSEMIDE 1,008 938 3 6
HYDROCODONE-ACETAMINOPHEN 1,000 842 S3 4 4
AMLODIPINE BESYLATE 938 844 5 5
LISINOPRIL 790 750 6 3
DONEPEZIL HCL 743 718 7 26
NAMENDA 709 672 8 34
METOPROLOL TARTRATE 625 580 9 10
SERTRALINE HCL 521 458 10 27
OMEPRAZOLE 509 465 11 7
JANTOVEN 487 426 12 163
POTASSIUM CHLORIDE 447 418 13 14
GABAPENTIN 444 355 14 13
TRAMADOL HCL 434 392 15 16
CITALOPRAM HBR 428 399 16 24
MIRTAZAPINE 386 375 17 54
FLUTICASONE PROPIONATE 350 320 18 32
CLOPIDOGREL 344 335 19 30
QUETIAPINE FUMARATE 337 326 20 66
LANTUS 334 286 21 45
METFORMIN HCL 333 271 22 8
RISPERIDONE 332 310 23 72
CARVEDILOL 310 304 24 21
CYMBALTA 303 269 25 44
DIGOXIN 294 288 26 55
EXELON 282 275 27 106
KLOR-CON M10 267 254 28 118
PRAVASTATIN SODIUM 265 244 29 12
ZOLPIDEM TARTRATE 264 231 30 17
ATORVASTATIN CALCIUM 249 210 31 9
KLOR-CON M20 246 205 32 90
PANTOPRAZOLE SODIUM 236 199 33 33
IPRATROPIUM-ALBUTEROL 233 214 34 150
METOPROLOL SUCCINATE 232 226 35 11
WARFARIN SODIUM 207 195 36 22
CARBIDOPA-LEVODOPA 207 203 36 113
HYDROCHLOROTHIAZIDE 205 187 38 15
PLAVIX 205 200 38 40
LIDODERM 203 176 40 105
TRAZODONE HCL 202 147 41 43
TAMSULOSIN HCL 202 172 41 29
HUMALOG 194 187 43 166
LOSARTAN POTASSIUM 190 171 44 18
FAMOTIDINE 190 179 44 75
NYSTATIN 183 165 46 178
ADVAIR DISKUS 179 173 47 60
DIVALPROEX SODIUM 176 144 48 100
CLONIDINE HCL 174 159 49 39
PREDNISONE 169 156 50 42
NOVOLOG 168 141 51 114
RANITIDINE HCL 167 150 52 56
VENLAFAXINE HCL ER 163 141 53 120
LEVETIRACETAM 160 119 54 103
LATANOPROST 155 155 55 197
ALENDRONATE SODIUM 153 139 56 23
ATENOLOL 149 144 57 25
DIOVAN 148 133 58 35
OLANZAPINE 145 128 59 137
SEROQUEL 144 138 60 143
BACLOFEN 143 76 61 121
FENTANYL 142 131 S2 62 126
FLUOXETINE HCL 141 137 63 83
GLIPIZIDE 141 137 63 50
HYDRALAZINE HCL 139 129 65 59
LEVOFLOXACIN 124 116 66 57
LYRICA 124 102 66 69
OXYBUTYNIN CHLORIDE ER 118 102 68 132
ISOSORBIDE MONONITRATE ER 118 108 68 51
CRESTOR 115 111 70 20
CIPROFLOXACIN HCL 112 105 71 47
DILTIAZEM 24HR CD 112 91 71 146
SPIRONOLACTONE 111 109 73 70
PAROXETINE HCL 108 94 74 84
BENICAR 102 102 75 138
DIVALPROEX SODIUM ER 98 89 76 185
ESCITALOPRAM OXALATE 94 82 77 62
DOXAZOSIN MESYLATE 93 82 78 94
PATANOL 92 91 79 237
LACTULOSE 92 82 79 111
GALANTAMINE HBR 92 79 79 325
ALBUTEROL SULFATE 88 78 82 134
CALCITONIN-SALMON 86 86 83 284
SINGULAIR 84 73 84 85
DILTIAZEM HCL 83 83 85 236
TIMOLOL MALEATE 82 78 86 348
TORSEMIDE 81 77 87 158
BENAZEPRIL HCL 79 61 88 77
ZETIA 79 79 88 81
SULFAMETHOXAZOLE-TRIMETHOPRIM 78 71 90 88
CLONIDINE 77 68 91 247
POLYETHYLENE GLYCOL 3350 75 70 92 93
VENLAFAXINE HCL 75 72 92 246
AGGRENOX 74 74 94 223
ABILIFY 73 44 95 172
TRAVATAN Z 73 67 95 239
ENALAPRIL MALEATE 72 72 97 49
MELOXICAM 71 70 98 31
ALLOPURINOL 71 59 98 37
SPIRIVA 70 69 100 79
NUEDEXTA 70 70 100 428
NIASPAN 69 69 102 127
RIVASTIGMINE 69 57 102 335
FINASTERIDE 68 60 104 102
GLIMEPIRIDE 68 65 104 36
ROPINIROLE HCL 67 66 106 115
NITROGLYCERIN PATCH 67 55 106 183
FENOFIBRATE 66 54 108 65
DOXYCYCLINE HYCLATE 66 62 108 123
LEVEMIR 63 50 110 135
TRIAMCINOLONE ACETONIDE 62 60 111 145
CEFUROXIME 61 57 112 130
JANUVIA 60 59 113 48
TRICOR 59 59 114 91
SODIUM CHLORIDE 59 21 114 371
NEXIUM 57 47 116 19
TERAZOSIN HCL 57 57 116 152
PROMETHAZINE HCL 56 51 R 118 96
MONTELUKAST SODIUM 54 44 119 153
SYNTHROID 52 52 120 52
PRAMIPEXOLE DIHYDROCHLORIDE 52 49 120 202
METHYLPREDNISOLONE 50 48 122 101
AMIODARONE HCL 50 47 122 167
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 26, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.